Evidence map›Paper›PMID 39861644›Full record

ArticlePlants (Basel, Switzerland)2025

Phenolic Compounds and Pharmacological Potential of

Olha Mykhailenko, Viktoriia Hurina, Nataliia Herbina, Yuliia Maslii, Liudas Ivanauskas, Inna Vladymyrova, Dmytro Lytkin, Zigmantas Gudžinskas, Hanna Severina, Olena Ruban and 1 more

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Pharmaceutical biology · 2026
    Review
  3. Article
  4. Plants (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Olha MykhailenkoDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine.ORCID 0000-0003-3822-8409
Viktoriia HurinaDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine.
Nataliia HerbinaDepartment of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Yuliia MasliiDepartment of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0000-0002-8968-0262
Liudas IvanauskasDepartment of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Inna VladymyrovaDepartment of Clinical Pharmacology, Institute for Advanced Training of Pharmacy Specialists, National University of Pharmacy, 61001 Kharkiv, Ukraine.
Dmytro LytkinEducational and Scientific Institute of Applied Pharmacy, National University of Pharmacy, 61000 Kharkiv, Ukraine.
Zigmantas GudžinskasNature Research Centre, Institute of Botany, Žaliųjų Ežerų Str. 47, 12200 Vilnius, Lithuania.ORCID 0000-0001-6230-5924
Hanna SeverinaDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine.ORCID 0000-0003-2894-9384
Olena RubanDepartment of Industrial Technology of Medicines and Cosmetics, National University of Pharmacy, 61168 Kharkiv, Ukraine.
Victoriya GeorgiyantsDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine.ORCID 0000-0001-8794-8010

Funding

Ministry of Health of Ukraine as part of the funding of a scientific topic: "Research of original substances for the correction of neurological deficits symptoms, prediction and assessment of factors affecting the mechanisms of action", 2023-2025 №: 0123U101751
6 · The paper itself

Abstract

The search for neuroprotective compounds in lavender is driven by its traditional use for brain health, with antioxidant activity serving as a key mechanism in reducing oxidative stress and supporting cognitive function. Lavender's potential to protect neurons is based on its calming, anti-stress properties, which increase the brain's resistance to neurodegeneration. Although lavender is not a traditional medicinal plant in Ukraine, it is increasingly recognised for its medicinal properties and is widely cultivated in the country. Lavender use in Ukraine is influenced by both global herbal practices and local medical traditions. The aim of this study was to optimise the preparation of lavender herb extracts, perform chemical profiling and evaluate their antioxidant and neuroprotective activities. The study focused on

Indexed as

antioxidant activityethnopharmacologyextractionLavandula angustifolialyophilised extractsneurotropic activityphenolic compounds

Identifiers

PMID39861644
PMCPMC11768821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.